Immune checkpoint inhibitors Market projected to reach $56,530 million by 2025. The market is segmented based on type, application, and region. The key players profiled in this report include AstraZeneca PLC., Bristol-Myers Squibb Company, Eli Lilly and Company (ARMO Biosciences.), Fortress Biotech, Inc.

Source: Click here